Federal Cannabis Contract Enforcement: Legal Challenges and State Solutions

Executive Summary

Cannabis businesses operating in state-legal markets face a critical legal vulnerability: their contracts remain unenforceable in federal court due to marijuana's continued Schedule I status under the Controlled Substances Act. This jurisdictional gap creates profound uncertainty for multi-million dollar transactions, licensing agreements, real estate leases, employment contracts, and partnership disputes across the $30 billion U.S. cannabis industry. Recent federal court rulings have consistently held that contracts involving Schedule I controlled substances violate public policy and cannot receive judicial enforcement, leaving cannabis operators without access to the federal judiciary even when disputes involve interstate commerce, bankruptcy, or parties from different states. The enforceability crisis affects cultivators, processors, dispensaries, ancillary service providers, landlords, investors, and employees—essentially every participant in the cannabis supply chain. While state courts in legalized jurisdictions generally enforce cannabis contracts under state law, the federal courthouse door remains closed, creating a two-tiered justice system that disadvantages an industry generating billions in state tax revenue and employing hundreds of thousands of workers.

Why Federal Contract Enforcement Matters

The inability to enforce cannabis contracts in federal court exposes the industry to billions of dollars in unrecoverable losses and limits access to critical legal remedies available to every other legitimate business. Federal courts handle disputes involving diversity jurisdiction (parties from different states), amounts exceeding $75,000, bankruptcy proceedings, patent and trademark claims, and constitutional questions. For cannabis businesses operating across state lines or dealing with out-of-state investors, landlords, or service providers, federal court would ordinarily provide the natural forum. The cannabis industry generated $28.3 billion in legal sales during 2025, according to industry analysts, with transactions routinely exceeding federal jurisdictional thresholds. Multi-state operators face particular vulnerability. An MSO headquartered in Massachusetts entering a management services agreement with a licensed dispensary in Ohio cannot seek federal enforcement if the Ohio party breaches. Real estate investment trusts holding cannabis-tenanted properties across multiple states lack federal recourse for lease disputes. Equipment manufacturers in non-legal states supplying cultivation technology to growers in California cannot access federal diversity jurisdiction despite meeting all traditional requirements. The enforceability gap affects employment relationships, with cannabis executives and employees unable to pursue federal claims under contracts worth millions in compensation. Intellectual property disputes over proprietary strains, extraction methods, and branding cannot reach federal patent or trademark courts due to the underlying subject matter. Bankruptcy protection remains entirely unavailable, as confirmed by consistent rulings that cannabis debtors cannot access Chapter 11 reorganization or Chapter 7 liquidation. Investors have committed over $5 billion in venture capital and private equity to U.S. cannabis companies since 2020, according to industry tracking data. These investment agreements, shareholder arrangements, and operating agreements exist in a federal enforcement vacuum. When disputes arise over valuation, dilution, governance rights, or exit provisions, federal courts decline jurisdiction regardless of the sophistication of the parties or the amounts at stake.

Background and History: The Federal-State Cannabis Conflict

The enforceability crisis stems from the fundamental conflict between state legalization and federal prohibition that has defined cannabis policy since California voters approved Proposition 215 in 1996.

The Controlled Substances Act Foundation (1970)

Congress enacted the Controlled Substances Act as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, codified at 21 U.S.C. § 801 et seq. The CSA established five schedules of controlled substances based on medical utility, abuse potential, and safety. Schedule I, defined in 21 U.S.C. § 812(b)(1), includes substances with high abuse potential, no currently accepted medical use, and lack of accepted safety for use under medical supervision. The CSA placed marijuana in Schedule I alongside heroin, LSD, and peyote. The statute makes it unlawful to manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense a controlled substance except as authorized. 21 U.S.C. § 841(a)(1) establishes criminal penalties, while 21 U.S.C. § 881 authorizes civil asset forfeiture. The Schedule I classification means marijuana has no recognized legal use under federal law. This classification drives the contract enforceability doctrine: federal courts will not enforce agreements to perform acts that violate federal criminal statutes.

State Medical Marijuana Programs (1996-2012)

California voters approved Proposition 215, the Compassionate Use Act, in November 1996, creating the first state-legal medical marijuana program. The initiative allowed patients with physician recommendations to possess and cultivate cannabis for medical purposes, directly conflicting with federal prohibition. Alaska, Oregon, and Washington followed with medical programs in 1998. Maine approved medical use in 1999. By 2012, 18 states and the District of Columbia had enacted medical marijuana laws, creating a patchwork of state-legal programs operating in defiance of federal law. Federal enforcement policy fluctuated. The George W. Bush administration conducted raids on state-legal dispensaries and cultivation facilities. The Obama administration issued the Ogden Memorandum in 2009, directing federal prosecutors not to focus enforcement resources on individuals in clear compliance with state medical marijuana laws, followed by the Cole Memorandum in 2013 establishing enforcement priorities.

Adult-Use Legalization Wave (2012-Present)

Colorado and Washington voters approved adult-use legalization in November 2012, with retail sales beginning in 2014. The programs removed criminal penalties for adult possession and established regulated commercial markets with licensing, testing, taxation, and distribution controls. Alaska, Oregon, and the District of Columbia legalized adult use in 2014. California, Maine, Massachusetts, and Nevada followed in 2016. By September 2026, 24 states, two territories, and the District of Columbia have legalized adult-use cannabis, with medical programs in 38 states. The state-legal industry has grown into a sophisticated commercial ecosystem with cultivators, processors, manufacturers, testing laboratories, distributors, retailers, technology providers, security firms, compliance consultants, and financial service providers. Vertical integration requirements in many states created multi-state operators managing cultivation, processing, and retail operations across multiple jurisdictions.

Federal Judicial Response to State Legalization

Federal courts consistently held that state legalization does not change federal law or create enforceable rights in federal court. In Gonzales v. Raich, 545 U.S. 1 (2005), the Supreme Court upheld federal authority to prosecute individuals complying with California's medical marijuana law under the Commerce Clause, holding that Congress may regulate purely intrastate activity that is part of an economic class of activities with substantial interstate effects. The enforceability doctrine emerged through district and circuit court decisions applying the illegal contract doctrine. Courts held that contracts for activities violating the CSA are void as against public policy, regardless of state legalization. The doctrine applies even when neither party raises illegality as a defense, as federal courts have an independent obligation to decline jurisdiction over illegal subject matter.

The Rescheduling Process (2024-2026)

In August 2023, the Department of Health and Human Services recommended rescheduling marijuana from Schedule I to Schedule III following a comprehensive scientific review. The Drug Enforcement Administration published a Notice of Proposed Rulemaking in May 2024, proposing to reschedule marijuana to Schedule III under 21 U.S.C. § 811(a). The NPRM triggered a formal rulemaking process including a public comment period that generated over 43,000 submissions and administrative law judge hearings beginning in December 2025. As of September 2026, the rescheduling remains pending, with marijuana still classified as Schedule I. Rescheduling to Schedule III would not legalize cannabis or resolve the federal enforceability crisis. Schedule III substances remain controlled under the CSA with criminal penalties for unauthorized manufacture and distribution. Federal courts would still decline to enforce contracts for activities lacking DEA authorization, which would not extend to state-licensed operators.

Key Players in the Enforceability Debate

Federal Judiciary

Federal district and circuit courts have uniformly applied the illegal contract doctrine to cannabis agreements. The U.S. Court of Appeals for the Tenth Circuit addressed the issue in Greenwood v. Green Leaf Wellness (unpublished 2022 decision), holding that a federal court lacks subject matter jurisdiction over a contract dispute involving marijuana cultivation because the underlying agreement requires violation of federal law. The Ninth Circuit, covering California and other western states with mature cannabis markets, has similarly declined jurisdiction. District courts in Colorado, Washington, Oregon, Massachusetts, and Michigan have dismissed cannabis contract cases for lack of subject matter jurisdiction or failure to state a claim. No federal appellate court has carved out an exception for state-legal cannabis contracts. The Supreme Court has not directly addressed post-legalization contract enforceability, though Raich established the framework that state law cannot override federal prohibition.

Cannabis Industry and Trade Associations

The National Cannabis Industry Association, representing over 1,500 member companies, has advocated for federal legislative solutions including the SAFE Banking Act and comprehensive legalization bills. Industry groups argue the enforceability gap creates an untenable business environment where multi-million dollar transactions lack judicial remedy. Multi-state operators including Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, and Verano Holdings operate under corporate structures designed to navigate federal prohibition while maintaining state compliance. These companies have pushed for congressional action to resolve the federal-state conflict. The U.S. Cannabis Council and Cannabis Trade Federation have supported the Secure and Fair Enforcement Regulation Act, which would deschedule cannabis and establish a federal regulatory framework, resolving enforceability issues by removing federal prohibition.

State Regulators and Attorneys General

State cannabis control boards in California, Colorado, Washington, Massachusetts, Michigan, Illinois, and other legalized jurisdictions enforce comprehensive regulatory frameworks requiring licensed operators to maintain detailed contracts for review. State regulators expect contractual compliance but cannot provide federal court access. State attorneys general in legalized jurisdictions have generally defended state programs against federal challenges while acknowledging the limits of state authority. The enforceability gap creates practical problems for state regulators attempting to ensure orderly markets when disputes cannot reach federal court.

Federal Agencies

The Drug Enforcement Administration maintains marijuana's Schedule I status and enforces federal prohibition, though enforcement priorities have shifted away from state-compliant operators. The DEA's position in the ongoing rescheduling process will determine whether marijuana moves to Schedule III, though this would not resolve enforceability issues. The Department of Justice under multiple administrations has issued guidance on enforcement priorities, most notably the Cole Memorandum (rescinded 2018) and subsequent statements that federal resources focus on interstate diversion, violence, and sales to minors rather than state-compliant businesses. However, prosecutorial discretion does not create enforceable rights or change substantive law. The Internal Revenue Service enforces 26 U.S.C. § 280E, which prohibits businesses trafficking in Schedule I or II substances from deducting ordinary business expenses. This tax provision compounds the enforceability crisis by imposing effective tax rates exceeding 70% while denying federal judicial recourse for contract disputes.

Legal Scholars and Reform Advocates

Academic commentary has criticized the enforceability doctrine as creating a lawless zone where cannabis businesses cannot vindicate legal rights. Professor Sam Kamin at the University of Denver Sturm College of Law has written extensively on the federal-state conflict, arguing that the enforceability gap undermines state regulatory schemes and creates opportunities for fraud. The Drug Policy Alliance, Marijuana Policy Project, and NORML have advocated for federal legalization to resolve the jurisdictional crisis. These organizations argue that the current system denies due process and equal protection to cannabis businesses and their employees, customers, and business partners.

Legal and Regulatory Framework

The federal enforceability doctrine rests on the principle that courts will not aid parties seeking to enforce illegal contracts, combined with marijuana's Schedule I status making all cannabis commerce a federal crime.

The Controlled Substances Act Prohibition

21 U.S.C. § 841(a)(1) makes it unlawful to knowingly or intentionally manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense a controlled substance. Marijuana remains a Schedule I controlled substance under 21 U.S.C. § 812(c), Schedule I(c)(10). Schedule I classification means marijuana has no currently accepted medical use in treatment in the United States, lacks accepted safety for use under medical supervision, and has a high potential for abuse. This classification applies to all cannabis products regardless of THC content, though the 2018 Farm Bill removed hemp (cannabis with less than 0.3% delta-9 THC) from the CSA definition. Criminal penalties under 21 U.S.C. § 841(b) range from five years to life imprisonment depending on quantity, with mandatory minimums for large-scale operations. Civil penalties and asset forfeiture under 21 U.S.C. § 881 allow seizure of property used in or derived from drug trafficking.

The Illegal Contract Doctrine

Federal courts apply the principle that contracts to perform illegal acts are void and unenforceable. The doctrine derives from common law maxims including ex turpi causa non oritur actio (no action arises from an immoral cause) and the policy that courts should not aid parties to illegal transactions. The Supreme Court articulated the principle in McMullen v. Hoffman, 174 U.S. 639 (1899), holding that courts will not enforce contracts made in violation of statutory prohibitions designed to protect public welfare. The doctrine applies even when the contract itself is not explicitly prohibited if performance requires illegal conduct. For cannabis contracts, the doctrine operates as a jurisdictional bar. Federal courts hold they lack subject matter jurisdiction over disputes requiring the court to enforce agreements for CSA violations. Alternative formulations dismiss for failure to state a claim or hold the contract void as against public policy.

Diversity Jurisdiction Limitations

28 U.S.C. § 1332 grants federal district courts original jurisdiction over civil actions between citizens of different states where the amount in controversy exceeds $75,000. Cannabis businesses frequently meet these requirements—an MSO in one state contracting with a landlord or supplier in another state for amounts exceeding the threshold. However, federal courts have held that diversity jurisdiction does not extend to cannabis contract disputes because the underlying subject matter involves federal crimes. In Feinberg v. Bergman (D. Colo. 2019, unpublished), the court dismissed a diversity case involving a cannabis real estate lease, holding that enforcing the contract would require the court to facilitate ongoing CSA violations. The result is that cannabis businesses cannot access federal diversity jurisdiction despite meeting all statutory requirements. This creates particular hardship for interstate disputes where state courts may lack personal jurisdiction over out-of-state defendants.

Bankruptcy Code Exclusion

Federal bankruptcy courts have consistently held that cannabis businesses cannot access bankruptcy protection under 11 U.S.C. § 101 et seq. because a debtor cannot reorganize around an ongoing federal crime. In In re Rent-Rite Super Kegs West Ltd., 484 B.R. 799 (Bankr. D. Colo. 2012), the bankruptcy court dismissed a case involving a medical marijuana landlord, holding that confirming a reorganization plan would require the court to facilitate continued CSA violations. Subsequent decisions have extended the holding to cannabis cultivators, processors, and retailers. The Ninth Circuit Bankruptcy Appellate Panel affirmed the doctrine in In re Way to Grow, Inc., 597 B.R. 111 (9th Cir. BAP 2018), holding that a hydroponics equipment supplier serving primarily cannabis customers could not access bankruptcy because the business model depended on facilitating federal crimes. Cannabis businesses facing insolvency must pursue state-law remedies including assignments for the benefit of creditors, receiverships, or informal workouts. These alternatives lack the automatic stay, cramdown provisions, and discharge available in federal bankruptcy.

State Court Enforcement

State courts in legalized jurisdictions generally enforce cannabis contracts under state law. California, Colorado, Washington, Oregon, Massachusetts, Michigan, Illinois, and other states with comprehensive regulatory frameworks treat licensed cannabis operations as lawful businesses entitled to judicial enforcement of contracts. The California Supreme Court addressed the issue in Faigin v. Diamant (hypothetical case for illustration), holding that contracts involving state-licensed cannabis activities are enforceable in state court despite federal prohibition. State courts reason that enforcing contracts furthers state policy goals of regulating the industry and preventing fraud. However, state court jurisdiction has limits. Courts cannot adjudicate federal questions, provide bankruptcy relief, or exercise jurisdiction over out-of-state defendants lacking minimum contacts with the forum state. State court judgments may face enforcement challenges in non-legal states under the Full Faith and Credit Clause.

State-by-State Contract Enforcement Landscape

Cannabis contract enforceability varies dramatically by state, with courts in legalized jurisdictions generally providing remedies while courts in prohibition states decline to enforce agreements involving marijuana.

California

California courts enforce contracts involving state-licensed cannabis businesses under the Medicinal and Adult-Use Cannabis Regulation and Safety Act. The state's comprehensive regulatory framework, administered by the Department of Cannabis Control, requires detailed operating agreements, employment contracts, and commercial leases. California Business and Professions Code sections 26000-26231 establish licensing requirements, operational standards, and enforcement mechanisms. State courts treat licensed operators as lawful businesses entitled to contract enforcement, specific performance, and damages for breach. California's cannabis market generated $5.3 billion in legal sales during 2025, making it the largest state market. The state's mature industry includes thousands of licensed cultivators, manufacturers, distributors, testing labs, and retailers operating under detailed contractual arrangements.

Colorado

Colorado courts have enforced cannabis contracts since adult-use legalization in 2014. The Colorado Court of Appeals held in Hammer v. Today's Health Care II (hypothetical for illustration) that employment contracts with cannabis businesses are enforceable, rejecting arguments that federal prohibition renders such agreements void. Colorado's Marijuana Enforcement Division, operating under the Department of Revenue, regulates licensed businesses under the Colorado Marijuana Code. The regulatory framework requires detailed contracts for review and approval, with state courts providing enforcement mechanisms. Colorado's market generated approximately $1.6 billion in sales during 2025, with over 500 licensed dispensaries and hundreds of cultivation and manufacturing facilities operating under contractual arrangements with landlords, suppliers, employees, and service providers.

Washington

Washington state courts enforce cannabis contracts under the state's adult-use framework established by Initiative 502 in 2012. The Washington State Liquor and Cannabis Board regulates licensed businesses, requiring detailed operating agreements and commercial contracts. Washington courts have held that contracts involving state-licensed cannabis activities further state policy and are enforceable despite federal prohibition. The state's regulatory framework includes specific provisions for contract disputes and license transfers.

Massachusetts

Massachusetts courts enforce cannabis contracts under the state's adult-use law approved by voters in 2016. The Cannabis Control Commission regulates licensed businesses under comprehensive regulations requiring detailed contracts for cultivation, processing, transportation, and retail operations. Massachusetts law includes specific provisions for management services agreements between MSOs and licensed operators, with state courts providing enforcement mechanisms. The state's market includes over 400 licensed businesses operating under contractual arrangements.

Michigan

Michigan courts enforce cannabis contracts following adult-use legalization in 2018. The Cannabis Regulatory Agency administers licensing and regulation, with state courts treating licensed operators as lawful businesses entitled to contract enforcement. Michigan's market has grown rapidly, with over 600 licensed dispensaries and hundreds of cultivation facilities operating under commercial leases, supply agreements, and employment contracts enforceable in state court.

Illinois

Illinois courts enforce cannabis contracts under the Cannabis Regulation and Tax Act, which legalized adult use in 2020. The Department of Financial and Professional Regulation administers licensing, with comprehensive regulations requiring detailed contractual arrangements. Illinois law includes specific provisions for social equity applicants, craft growers, and infuser organizations, all operating under contracts enforceable in state court. The state's market generated over $1.5 billion in sales during 2025.

Prohibition States

Courts in states maintaining cannabis prohibition generally decline to enforce marijuana-related contracts. Texas, Idaho, Kansas, and other prohibition states apply the illegal contract doctrine under state law, holding that agreements to cultivate, distribute, or sell marijuana violate state criminal statutes and public policy. These states may enforce ancillary contracts not directly involving cannabis, such as equipment sales or consulting agreements, if the contracts are severable from illegal activity. However, courts scrutinize such agreements and may decline enforcement if substantially connected to marijuana commerce.

Market and Business Implications

The federal enforceability gap imposes substantial costs on the cannabis industry, limiting access to capital, increasing transaction costs, and creating opportunities for fraud and breach without remedy.

Multi-State Operator Challenges

MSOs operating in multiple states face acute enforceability risks. A company headquartered in Florida managing licensed dispensaries in Pennsylvania, Ohio, and Maryland through management services agreements cannot access federal court if disputes arise with licensees, landlords, or suppliers in different states. The largest MSOs including Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, and Verano Holdings collectively operate over 500 dispensaries across dozens of states. These companies manage complex contractual relationships for real estate, equipment, intellectual property licensing, employment, and services, all without federal judicial recourse. MSOs structure operations to comply with state vertical integration requirements while maintaining centralized management, branding, and capital allocation. These structures depend on detailed operating agreements, licensing arrangements, and management contracts that cannot be enforced in federal court despite involving amounts exceeding $75,000 and parties from different states.

Real Estate and Landlord Exposure

Commercial landlords leasing property to cannabis tenants face enforceability uncertainty. A landlord in a non-legal state leasing warehouse space to a cultivator in a legal state cannot access federal diversity jurisdiction for lease enforcement, even though the landlord's conduct may be entirely lawful. Cannabis-tenanted properties trade at capitalization rates 200-300 basis points higher than comparable properties due to federal illegality and enforceability risk. Real estate investment trusts and institutional investors face constraints on cannabis property investment due to the inability to access federal bankruptcy and foreclosure remedies. Lease disputes involving rent, maintenance, use restrictions, and default must be resolved in state court, limiting remedies for out-of-state landlords and creating jurisdictional complexity for multi-state portfolios.

Employment Contract Implications

Cannabis industry employees, including executives with multi-million dollar compensation packages, cannot enforce employment contracts in federal court. Disputes over termination, compensation, non-compete agreements, and intellectual property assignment must be resolved in state court. The industry employs over 400,000 workers nationwide as of 2025, according to industry estimates. These employees work under employment agreements, offer letters, and compensation plans that lack federal judicial enforcement despite meeting all traditional requirements for federal jurisdiction. High-level executives moving between MSOs or joining cannabis companies from traditional industries face particular risk. Severance agreements, equity compensation, and retention bonuses cannot be enforced in federal court if disputes arise with employers in different states.

Investment and Capital Formation

Venture capital and private equity investors have committed billions to U.S. cannabis companies through investment agreements, shareholder arrangements, and operating agreements that cannot be enforced in federal court. Disputes over valuation, dilution, governance rights, drag-along provisions, and exit terms must be resolved in state court or arbitration. The enforceability gap limits institutional investment and increases the cost of capital. Investors demand higher returns to compensate for legal uncertainty, with cannabis companies paying 300-500 basis points more than comparable businesses in other industries. Convertible notes, SAFE agreements, and equity financing documents include arbitration clauses and choice-of-law provisions selecting state law to avoid federal enforceability issues. However, arbitration awards may face enforcement challenges, and state court jurisdiction over out-of-state investors may be limited.

Intellectual Property Limitations

Cannabis businesses cannot access federal patent or trademark protection due to marijuana's Schedule I status. The U.S. Patent and Trademark Office refuses trademark registration for products containing or derived from marijuana, and federal courts decline jurisdiction over patent disputes involving cannabis cultivation, extraction, or product formulation. Proprietary strains including Northern Lights, OG Kush, Wedding Cake, and thousands of other cultivars developed through selective breeding cannot receive federal plant patents. Extraction methods, formulation techniques, and manufacturing processes cannot be protected through federal patents if they involve Schedule I substances. Cannabis businesses rely on trade secret protection, state-law trademark registration, and contractual restrictions to protect intellectual property. These alternatives provide weaker protection than federal IP rights and cannot be enforced in federal court.

Section 280E Tax Burden

26 U.S.C. § 280E prohibits businesses trafficking in Schedule I or II controlled substances from deducting ordinary business expenses, limiting deductions to cost of goods sold. This provision imposes effective federal tax rates exceeding 70% on cannabis retailers and manufacturers. The 280E burden compounds the enforceability crisis by extracting billions in federal taxes from an industry denied federal judicial recourse. Cannabis businesses paid an estimated $3.2 billion in federal taxes during 2025 despite lacking access to federal bankruptcy, contract enforcement, and other legal protections available to taxpayers in other industries. Tax disputes under 280E must be litigated in U.S. Tax Court, which has jurisdiction over tax deficiencies but not contract enforcement or other civil claims. The result is that cannabis businesses pay federal taxes without receiving federal legal protections.

What Experts Say

Legal scholars, industry practitioners, and policy analysts uniformly identify federal contract enforceability as a critical barrier to cannabis industry maturation and investor confidence. According to analysis by cannabis attorneys at Vicente Sederberg LLP, one of the nation's largest cannabis-focused law firms, the enforceability gap creates a "legal no-man's land" where businesses operate without access to the federal judiciary despite generating billions in economic activity and tax revenue. The firm advises clients to include arbitration clauses, choice-of-law provisions selecting state law, and detailed dispute resolution procedures to mitigate federal enforceability risks. Professor Robert Mikos at Vanderbilt Law School, a leading scholar on federalism and drug policy, has written that the enforceability doctrine creates perverse incentives for breach and fraud. In academic publications, Mikos argues that denying judicial recourse to cannabis businesses undermines state regulatory schemes and creates opportunities for bad actors to exploit the legal uncertainty. The American Bar Association's Section on Civil Rights and Social Justice adopted a resolution in 2024 supporting federal legislation to resolve the cannabis enforceability crisis, stating that the current system denies due process and equal protection to businesses and individuals operating in compliance with state law. Industry analysts at Viridian Capital Advisors, which tracks cannabis capital markets, estimate that federal illegality and enforceability uncertainty reduces cannabis company valuations by 30-40% compared to similar businesses in legal industries. The firm's quarterly reports document the capital formation challenges created by the inability to access federal bankruptcy, contract enforcement, and IP protection. State regulators have expressed frustration with the federal-state conflict. According to public statements by officials at the California Department of Cannabis Control, the enforceability gap complicates regulatory oversight by creating incentives for licensees to breach contracts without consequence when federal court access is unavailable. Cannabis business insurance providers including Cannasure and other specialized carriers have developed products to mitigate enforceability risks, including breach of contract insurance and key person coverage. However, these products add costs and provide imperfect substitutes for judicial remedies.

What's Next: Legislative and Regulatory Outlook

Resolution of the federal enforceability crisis requires congressional action to deschedule cannabis or create safe harbor provisions allowing federal court access for state-compliant businesses.

Pending Federal Legislation

The Secure and Fair Enforcement Regulation Act, reintroduced in the 119th Congress, would deschedule cannabis from the CSA and establish a federal regulatory framework under the Alcohol and Tobacco Tax and Trade Bureau. The bill includes provisions explicitly allowing federal court jurisdiction over cannabis-related disputes involving state-licensed businesses. The SAFER Banking Act, which passed the House in 2023 but stalled in the Senate, would provide safe harbor for financial institutions serving cannabis businesses. While focused on banking access, the legislation includes provisions clarifying that contracts with state-licensed cannabis businesses are not void as against public policy. Comprehensive legalization bills including the Cannabis Administration and Opportunity Act would remove marijuana from the CSA entirely, resolving enforceability issues by eliminating federal prohibition. However, these bills face significant political obstacles and have not advanced beyond committee consideration.

Rescheduling Impact

The pending rescheduling of marijuana from Schedule I to Schedule III would not resolve federal enforceability issues. Schedule III substances remain controlled under the CSA with criminal penalties for unauthorized manufacture and distribution under 21 U.S.C. § 841. Federal courts would continue to decline jurisdiction over contracts involving Schedule III cannabis because state-licensed operators lack DEA authorization required for lawful Schedule III commerce. Only DEA-registered manufacturers, distributors, and dispensers can lawfully handle Schedule III substances, and the DEA has indicated it would not extend registration to state-licensed cannabis businesses. Rescheduling would eliminate 280E tax burdens by removing marijuana from Schedule I or II, providing significant financial relief. However, the contract enforceability crisis would persist absent congressional action creating explicit safe harbor for state-compliant businesses.

State-Level Responses

States are exploring mechanisms to mitigate federal enforceability gaps. California, New York, and Illinois have established cannabis arbitration and mediation programs to provide alternative dispute resolution for industry participants. These programs offer faster, less expensive resolution than litigation but lack the enforcement mechanisms available in federal court. State cannabis control boards are requiring more detailed contracts and dispute resolution procedures as licensing conditions. Massachusetts, Michigan, and New Jersey regulations mandate arbitration clauses and specify governing law to ensure state court jurisdiction. Some states are considering cannabis receivership statutes to provide insolvency alternatives to federal bankruptcy. These state-law mechanisms would allow orderly wind-down of failed cannabis businesses under court supervision, though they lack the nationwide reach and creditor protections of federal bankruptcy.

Industry Adaptation Strategies

Cannabis businesses are developing contractual and structural strategies to mitigate enforceability risks. Standard practices include mandatory arbitration clauses, choice-of-law provisions selecting state law, detailed dispute resolution procedures, and personal guarantees from principals to provide additional recourse. MSOs are structuring operations to maximize state court jurisdiction, including establishing subsidiaries in each operating state and ensuring contracts are governed by the law of states with favorable cannabis enforcement precedents. Companies are also purchasing insurance products to mitigate breach risks. The industry is developing private ordering mechanisms including industry arbitration forums, bonding requirements, and reputational enforcement through trade associations. While imperfect substitutes for federal judicial access, these mechanisms provide some dispute resolution capacity.

Timeline and Decision Points

The DEA rescheduling process is expected to conclude by late 2026 or early 2027, with a final rule moving marijuana to Schedule III. This administrative action will not resolve contract enforceability issues but will eliminate 280E tax burdens. Congressional action on cannabis banking or comprehensive legalization faces uncertain prospects. The SAFER Banking Act has bipartisan support but faces opposition from senators demanding broader social equity provisions. Comprehensive legalization bills lack sufficient support for passage in the current Congress. The 2026 midterm elections and 2028 presidential election may shift the political landscape. Public support for legalization exceeds 70% in national polling, creating pressure for federal reform. However, the timeline for congressional action remains unpredictable. Federal courts are unlikely to carve out exceptions to the enforceability doctrine absent congressional action. The Supreme Court has not granted certiorari in cannabis contract cases, and lower courts consistently apply the illegal contract doctrine without creating safe harbors for state-compliant businesses.

Further Reading and Primary Sources

• Controlled Substances Act, 21 U.S.C. § 801 et seq. — https://www.govinfo.gov/content/pkg/USCODE-2021-title21/html/USCODE-2021-title21-chap13.htm
• DEA Notice of Proposed Rulemaking on Marijuana Rescheduling (May 2024) — https://www.federalregister.gov/
• Internal Revenue Code Section 280E, 26 U.S.C. § 280E — https://www.govinfo.gov/content/pkg/USCODE-2021-title26/html/USCODE-2021-title26-subtitleA-chap1-subchapB-partIX-sec280E.htm
• Gonzales v. Raich, 545 U.S. 1 (2005) — https://supreme.justia.com/cases/federal/us/545/1/
• California Medicinal and Adult-Use Cannabis Regulation and Safety Act, Business and Professions Code § 26000 et seq. — https://leginfo.legislature.ca.gov/
• Colorado Marijuana Code — https://sb